Differential (Click to cross reference) advances in neurology Alzheimer's disease amnesia amnesia, anterograde amygdala anemia angiotensin II receptor blocker angiotensin-converting enzyme, inhibitors antihypertensive antiviral agents blood pressure bone marrow transplantation candesartan CAT scan, emission, abnormal cataracts central nervous system, infection of cerebrovascular accident cerebrovascular accident, prevention of chemotherapy, CNS treatment and complications with children chronic graft versus host disease complications controversies in neurology cyclosporine dementia, prevention of diuretic efficacy electroencephalogram, abnormalities of encephalitis encephalitis, viral herpes virus herpes virus infection hippocampus Hodgkin's disease human herpesvirus 6 hypertension iatrogenic neurologic disorders immunosuppression immunosuppressive agents inappropriate antidiuretic(A.D.H.)hormone indapamide intracerebral hemorrhage leukemia leukemia, neurologic findings assoc.with leukoencephalopathy limbic encephalitis lymph node biopsy lymphadenopathy lymphadenopathy, cervical migraine migraine, prophylaxis monoclonal gammopathy mortality MRI MRI, abnormal MRI, contrast enhanced multiple myeloma myelodysplasia neuralgia, treatment of neuroprotective agents neurotoxic night sweats opportunistic infection opportunistic infection, CNS organ transplantation pain pain, neuropathic perindopril peripheral blood stem cell transplantation pleocytosis of cerebrospinal fluid polymerase chain reaction post herpetic neuralgia post transplant lymphoproliferative disease prevention of neurologic disorders prognosis PROGRESS trial radiation therapy, CNS treatment and complications with radiation therapy, total body ramipril rash review article risk factors safety seizure seizure, treatment of stem cell transplantation temporal lobe, lesion, bilateral thrombocytopenia treatment of neurologic disorder uncus viral infection viral infection, CNS vision, blurred visual impairment

Showing articles 0 to 11 of 11 Clinicopathologic Conference, Plasm-Cell Myeloma Post-Transplant Lymphoproliferative Disorder NEJM 386:2508-2516, Case 20-2022, 2022 EMA401, An Orally Administered Highly Selective Angiotensin II Type 2 Receptor Antagonist, as a Novel Treatment for Postherpetic Neuralgia: A Randomised, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial Lancet 383:1637-1647, Rice, A.C.,et al, 2014 Use of Angiotension Receptor Blockers and Risk of Dementia in a Predominantly Male Population: Prospective Cohort Analysis BMJ 340:141-147, 111, Li,N.-C.,et al, 2010 Angiotensin Receptor Blockers Should Be Regarded as First-Line Drugs for Stroke Prevention in Both Primary and Secondary Prevention Settings: No Stroke 40:3161-3162, 3163, Strauss,M. &Hall,A., 2009 Angiotensin Receptor Blockers Should Be Regarded as First-Line Drugs for Stroke Prevention in Both Primary and Secondary Prevention Settings: Yes Stroke 40:3159-3160, 3163, Hackam,D., 2009 Post-Transplant Acute Limbic Encephalitis: Clinical Features and Relationship to HHV6 Neurol 69:156-165, Seeley,W.W.,et al, 2007 MR Imaging of Human Herpesvirus-6-Associated Encephalitis in 4 Patients with Anterograde Amnesia after Allogeneic Hematopoietic Stem-Cell Transplantation AJNR 27:887-891, Gorniak,R.J.T.,et al, 2006 Prophylactic Treatment of Migraine With an Angiotnesin II Receptor Blocker JAMA 289:65-69, Tronvik,E.,et al, 2003 Blood Pressure-Lowering for Secondary Prevention of Stroke: ACE Inhibition Is Not the Key Stroke 34:1334-1335,1335, Bath,P., 2003 Blood Pressure--Lowering for Secondary Prevention of Stroke: ACE Inhibition Is the Key Stroke 34:1333-1334,1334, Anderson,C., 2003 Severe Neurologic Complications After Hematopoietic Stem Cell Transplantation in Children Neurol 59:1895-1904,E13, Farci,M.,et al, 2002 Showing articles 0 to 11 of 11